Roger Song
Stock Analyst at Jefferies
(0.64)
# 3,714
Out of 4,829 analysts
46
Total ratings
31.25%
Success rate
-18.44%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Roger Song
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KNSA Kiniksa Pharmaceuticals International, | Maintains: Buy | $40 → $45 | $26.84 | +67.66% | 2 | Apr 29, 2025 | |
| NKTR Nektar Therapeutics | Upgrades: Buy | $1 → $2 | $0.71 | +179.80% | 11 | Apr 11, 2025 | |
| AKBA Akebia Therapeutics | Initiates: Buy | $6 | $2.43 | +146.91% | 1 | Apr 1, 2025 | |
| SANA Sana Biotechnology | Initiates: Buy | $7 | $2.00 | +250.00% | 1 | Mar 14, 2025 | |
| KRYS Krystal Biotech | Initiates: Buy | $245 | $139.43 | +75.72% | 1 | Mar 5, 2025 | |
| WVE Wave Life Sciences | Initiates: Buy | $26 | $6.60 | +293.94% | 1 | Feb 25, 2025 | |
| IGMS IGM Biosciences | Downgrades: Hold | $48 → $2 | $1.19 | +68.07% | 2 | Jan 10, 2025 | |
| BIOA BioAge Labs | Downgrades: Hold | $42 → $7 | $4.07 | +71.99% | 2 | Dec 9, 2024 | |
| REPL Replimune Group | Maintains: Buy | $16 → $19 | $7.85 | +142.04% | 1 | Dec 4, 2024 | |
| KURA Kura Oncology | Maintains: Buy | $32 → $28 | $6.09 | +360.15% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $2 → $7 | $1.25 | +460.00% | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $89 | $46.65 | +90.78% | 1 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $25 | $6.34 | +294.32% | 2 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $41 | $10.18 | +302.75% | 1 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $9.74 | +259.34% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $3.24 | +177.78% | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $129 | $31.59 | +308.36% | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $2.5 → $8 | $2.13 | +275.59% | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $97 | $73.59 | +31.81% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $72 | $15.80 | +355.70% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $110 | $28.30 | +288.69% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $35 | $6.01 | +482.36% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $0.88 | +917.41% | 1 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $4.06 | +97.29% | 2 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $0.26 | +1,457.63% | 2 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $0.87 | +2,321.31% | 1 | Sep 2, 2020 |
Kiniksa Pharmaceuticals International,
Apr 29, 2025
Maintains: Buy
Price Target: $40 → $45
Current: $26.84
Upside: +67.66%
Nektar Therapeutics
Apr 11, 2025
Upgrades: Buy
Price Target: $1 → $2
Current: $0.71
Upside: +179.80%
Akebia Therapeutics
Apr 1, 2025
Initiates: Buy
Price Target: $6
Current: $2.43
Upside: +146.91%
Sana Biotechnology
Mar 14, 2025
Initiates: Buy
Price Target: $7
Current: $2.00
Upside: +250.00%
Krystal Biotech
Mar 5, 2025
Initiates: Buy
Price Target: $245
Current: $139.43
Upside: +75.72%
Wave Life Sciences
Feb 25, 2025
Initiates: Buy
Price Target: $26
Current: $6.60
Upside: +293.94%
IGM Biosciences
Jan 10, 2025
Downgrades: Hold
Price Target: $48 → $2
Current: $1.19
Upside: +68.07%
BioAge Labs
Dec 9, 2024
Downgrades: Hold
Price Target: $42 → $7
Current: $4.07
Upside: +71.99%
Replimune Group
Dec 4, 2024
Maintains: Buy
Price Target: $16 → $19
Current: $7.85
Upside: +142.04%
Kura Oncology
Nov 21, 2024
Maintains: Buy
Price Target: $32 → $28
Current: $6.09
Upside: +360.15%
Nov 19, 2024
Upgrades: Buy
Price Target: $2 → $7
Current: $1.25
Upside: +460.00%
Oct 23, 2024
Initiates: Buy
Price Target: $89
Current: $46.65
Upside: +90.78%
Oct 16, 2024
Maintains: Buy
Price Target: $31 → $25
Current: $6.34
Upside: +294.32%
Oct 11, 2024
Initiates: Buy
Price Target: $41
Current: $10.18
Upside: +302.75%
Oct 8, 2024
Initiates: Buy
Price Target: $35
Current: $9.74
Upside: +259.34%
Sep 5, 2024
Initiates: Buy
Price Target: $9
Current: $3.24
Upside: +177.78%
Sep 3, 2024
Maintains: Buy
Price Target: $108 → $129
Current: $31.59
Upside: +308.36%
May 6, 2024
Upgrades: Buy
Price Target: $2.5 → $8
Current: $2.13
Upside: +275.59%
Apr 17, 2024
Initiates: Buy
Price Target: $97
Current: $73.59
Upside: +31.81%
Mar 20, 2024
Maintains: Buy
Price Target: $41 → $72
Current: $15.80
Upside: +355.70%
Mar 7, 2024
Initiates: Buy
Price Target: $110
Current: $28.30
Upside: +288.69%
Aug 31, 2022
Maintains: Buy
Price Target: $30 → $35
Current: $6.01
Upside: +482.36%
Jul 29, 2022
Initiates: Buy
Price Target: $9
Current: $0.88
Upside: +917.41%
Dec 1, 2021
Initiates: Buy
Price Target: $8
Current: $4.06
Upside: +97.29%
Nov 12, 2021
Upgrades: Buy
Price Target: $3 → $4
Current: $0.26
Upside: +1,457.63%
Sep 2, 2020
Initiates: Buy
Price Target: $21
Current: $0.87
Upside: +2,321.31%